A Study to Assess the Safety and Efficacy of Inclacumab in Participants With Sickle Cell Disease Experiencing Vasoocclusive Crises
A Randomized, Double-blind, Placebo-controlled, Multicenter Study to Assess the Safety and Efficacy of Inclacumab in Participants With Sickle Cell Disease Experiencing Vaso-occlusive Crises
Category & Conditions: Rare Diseases
Medicine: INCLACUMAB(PF-07940370)
ClinicalTrials.gov Identifier (NCT): NCT04935879
Protocol ID: GBT2104-131 (C5361001)
Open Plain Language Summary Result:
Click here